Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06783868 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control

Study acronym: SAVE STROKE II
StatusNot Yet Recruiting
PhaseNot specified
Started2025-10
View on ClinicalTrials.gov ↗
A prospective, non-blinded, multi-center study to assess the impact of early Catheter Ablation (CA) in patients with a new diagnosis of Atrial Fibrillation(AF) at the time of stroke. 100 patients will be enrolled.

Amendment record

Amended 2 times since 2025-01-14; most recent filed 2025-08-27. Every amendment is listed below.

Dates here are the day the sponsor filed the amendment, not the day ClinicalTrials.gov published it. Version history last read from ClinicalTrials.gov on 2026-08-30.

2025-08-27
Amendment Study Status v2
2025-03-14
Amendment Study Status v1
2025-01-14
Original filing
Trial Details
NCT Number NCT06783868
Lead Sponsor Kansas City Heart Rhythm Research Foundation
Conditions Atrial Fibrillation, Stroke
Enrollment 100 participants
Start Date 2025-10
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2025-08-28